These results were supported by the negative correlation between miR-1 expression and mRNA expression of MET and VEGF-A in our Chinese cohort (see online resource 2a and b in the electronic supplementary material) as well as the GC patients recruited in TCGA (see Online Resource 2d and e in the electronic supplementary material). This evidence concerns the gene MET and gastric cancer.